お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の埋込型除細動器市場(2019年~2025年)
市場調査レポート
商品コード
923819

世界の埋込型除細動器市場(2019年~2025年)

Implantable Cardioverter Defibrillators Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
世界の埋込型除細動器市場(2019年~2025年)
出版日: 2020年01月14日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは世界の埋込型除細動器(ICD)市場について調査しており、市場機会、成長および阻害要因、製品・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 レポートの概要

  • 調査方法とツール
  • 市場分析
    • セグメント別
    • 地域別
    • 利害関係者別

第2章 市場の概要と洞察

  • レポートの範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 提言
    • 結論
  • 規則と規制

第3章 競合情勢、

  • 競合ダッシュボード
  • 主要戦略分析
  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の進展

第4章 市場の決定要因

  • 成長要因
  • 阻害要因
  • 市場機会

第5章 市場セグメンテーション

  • 製品別
    • 経静脈埋込型除細動器(T-ICDS)
    • 皮下埋込型除細動器(S-ICDS)
  • エンドユーザー別
    • 病院
    • 診断センター
    • 外来サービス
    • ホームケア

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • その他
  • その他の地域

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cintas Corp.
  • Defibtech, LLC
  • General Electric Co.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • 日本光電工業株式会社
  • Stryker Corp.
図表

LIST OF TABLES

  • No. # 1. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • No. # 2. GLOBAL TRANSVENOUS IMPLANTABLECARDIOVERTER DEFIBRILLATOR (T-ICDS) MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 3. GLOBAL SUBCUTANEOUS IMPLANTABLECARDIOVERTER DEFIBRILLATOR (S-ICDS)MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 4. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
  • No. # 5. GLOBAL HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 6. GLOBAL DIAGNOSTIC CENTERSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 7. GLOBAL AMBULATORY SERVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 8. GLOBAL HOMECARE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • No. # 9. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • No. # 10. NORTH AMERICAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • No. # 11. NORTH AMERICAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • No. # 12. NORTH AMERICAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
  • No. # 13. EUROPEAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • No. # 14. EUROPEAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • No. # 15. EUROPEAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
  • No. # 16. ASIA-PACIFIC IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • No. # 17. ASIA-PACIFIC IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • No. # 18. ASIA-PACIFIC IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)
  • No. # 19. REST OF THE WORLD IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
  • No. # 20. REST OF THE WORLD IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET RESEARCH AND ANALYSIS BY END-USERS, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • No. # 1. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SHARE BY PRODUCT, 2018 VS 2025 (%)
  • No. # 2. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SHARE BY END-USERS, 2018 VS 2025 (%)
  • No. # 3. GLOBAL IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • No. # 4. US IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 5. CANADA IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 6. UK IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 7. FRANCE IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 8. GERMANY IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 9. ITALY IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 10. SPAIN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 11. ROE IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 12. INDIA IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 13. CHINA IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 14. JAPAN IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 15. REST OF ASIA-PACIFIC IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
  • No. # 16. REST OF THE WORLD IMPLANTABLECARDIOVERTER DEFIBRILLATOR MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2020236

Implantable Cardioverter Defibrillators (ICD)s are battery-powered devices placed under the skin for keeping a track of heart rate. It has been proved quite useful in preventing sudden death in patients suffering from sustained ventricular tachycardia or fibrillation. ICD holds a critical role in preventing cardiac arrest in high-risk patients who are more prone to life-threatening ventricular arrhythmias. In this process, ICD is connected through thin wires with the patient's heart.

The device delivers an electric shock to restore a normal heartbeat in case of an abnormal heart rhythm, if patient's heart is beating chaotically and much too fast. Though ICDs have demonstrated clear life-saving benefits; concerns about patient acceptance along with psychological adjustment to the ICD have been the focus of much research.

As per researchers, the Quality of Life (QoL) of ICD patients can be better than that of those taking anti-arrhythmic medications. Usually, ICDs are composed of an ICD generator and wires; the first component consists of a programmable software, computer chip or circuitry with RAM (memory), a capacitor and a battery. There are two type of ICDS namely, Transvenous (TV) patients are vulnerable to complications such as fractures, which can turn to inappropriate therapy and infections. Additionally, a device-related infection rate generally varies between 0.67% and 1.49% over a 3 to 12-month follow-up. Moreover, mechanical lead failures can arouse from hardware malfunction, which can further result in inappropriate shocks, over sensing, and inability to deliver appropriate therapy. Furthermore, long-term lead failure rates up to 20% have been reported with Transvenous defibrillators.

Subcutaneous ICD is alternative novel technology used to limit complications associated with transvenous implantable cardioverter-defibrillator. Traditionally, S-ICD was used in patients with difficult venous access. As a result, congenital heart disease patients with venous anomalies are considered good candidates for S-ICD. Additionally, patients who are expected to outlive the life expectancy of their TV leads and requiring device extractions later in life can be ideal for S-ICD. It may also be used in patients with channelopathies or those who undergo renal replacement therapies and require chronic venous access.

Research Methodology

The market study of the Implantable Cardioverter Defibrillators market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis.The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • No. # 1. Implantable Cardioverter Defibrillators Market Research and Analysis by Product
  • No. # 2. Implantable Cardioverter Defibrillators Market Research and Analysis by End-users

The Report Covers:

  • Comprehensive research methodology of the Implantable Cardioverter Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Implantable Cardioverter Defibrillators market.
  • Insights about market determinants which are stimulating the Implantable Cardioverter Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Competitive Dashboard
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Implantable CardioverterDefibrillator Market by Product
    • 5.1.1. Transvenous Implantable CardioverterDefibrillator (T-ICDS)
    • 5.1.2. Subcutaneous Implantable CardioverterDefibrillator (S-ICDS)
  • 5.2. Global Implantable CardioverterDefibrillator Market by End-Users
    • 5.2.1. Hospitals
    • 5.2.2. Diagnostic Centers
    • 5.2.3. Ambulatory Service
    • 5.2.4. Homecare

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

Abbott Laboratories, Inc.

Biotronik SE & Co. KG

Cintas Corp.

Defibtech, LLC

General Electric Co.

Koninklijke Philips N.V.

LivaNova PLC

Medtronic PLC

Nihon Kohden Corp.

Stryker Corp.

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.